BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32993084)

  • 1. Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction.
    Mayr F; Möller G; Garscha U; Fischer J; Rodríguez Castaño P; Inderbinen SG; Temml V; Waltenberger B; Schwaiger S; Hartmann RW; Gege C; Martens S; Odermatt A; Pandey AV; Werz O; Adamski J; Stuppner H; Schuster D
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I.
    Herrmann FC; Sivakumar N; Jose J; Costi MP; Pozzi C; Schmidt TJ
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29211037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening.
    Brozic P; Turk S; Lanisnik Rizner T; Gobec S
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):245-50. PubMed ID: 18765269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
    Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
    Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico analyses of natural products on leishmania enzyme targets.
    Scotti L; Ishiki H; Mendonça Júnior FJ; Da Silva MS; Scotti MT
    Mini Rev Med Chem; 2015; 15(3):253-69. PubMed ID: 25769973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico search for drug targets of natural compounds.
    Yao L
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1632-9. PubMed ID: 22039820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cheminformatics in Natural Product-based Drug Discovery.
    Chen Y; Kirchmair J
    Mol Inform; 2020 Dec; 39(12):e2000171. PubMed ID: 32725781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counting on natural products for drug design.
    Rodrigues T; Reker D; Schneider P; Schneider G
    Nat Chem; 2016 Jun; 8(6):531-41. PubMed ID: 27219696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Assisted Drug Virtual Screening Based on the Natural Product Databases.
    Yang B; Mao J; Gao B; Lu X
    Curr Pharm Biotechnol; 2019; 20(4):293-301. PubMed ID: 30919773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advance in the discovery of tyrosinase inhibitors from natural sources via separation methods.
    Zhang XW; Bian GL; Kang PY; Cheng XJ; Yan K; Liu YL; Gao YX; Li DQ
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2104-2117. PubMed ID: 34579614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitor.
    Watanabe K; Kakefuda A; Yasuda M; Enjo K; Kikuchi A; Furutani T; Naritomi Y; Otsuka Y; Okada M; Ohta M
    Bioorg Med Chem; 2013 Sep; 21(17):5261-70. PubMed ID: 23845281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining Natural Products for Macrocycles to Drug Difficult Targets.
    Begnini F; Poongavanam V; Over B; Castaldo M; Geschwindner S; Johansson P; Tyagi M; Tyrchan C; Wissler L; Sjö P; Schiesser S; Kihlberg J
    J Med Chem; 2021 Jan; 64(2):1054-1072. PubMed ID: 33337880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach.
    Medina-Franco JL; López-Vallejo F; Kuck D; Lyko F
    Mol Divers; 2011 May; 15(2):293-304. PubMed ID: 20697809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Natural Lead Molecules Against Putative Molecular Targets of Drug-resistant Cryptococcus spp: An Insight from Computer-aided Molecular Design.
    Manjunath M; Skariyachan S
    Curr Top Med Chem; 2018; 18(31):2681-2701. PubMed ID: 30659541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.
    Thomford NE; Senthebane DA; Rowe A; Munro D; Seele P; Maroyi A; Dzobo K
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of natural products as selective PTP1B inhibitors via virtual screening.
    Yang Y; Tian JY; Ye F; Xiao Z
    Bioorg Chem; 2020 May; 98():103706. PubMed ID: 32199302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bioactive natural products by pharmacophore-based virtual screening.
    Schuster D; Wolber G
    Curr Pharm Des; 2010 May; 16(15):1666-81. PubMed ID: 20222852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.